Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


03.10.2017

1 Brain Res
1 J Clin Pharmacol
1 J Neurol Neurosurg Psychiatry
1 J Neurosci
2 Lancet Neurol
4 Mov Disord
1 Nat Rev Neurol
1 Neurol Genet
3 Neurology
1 Neurosci Lett
5 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Brain Res

  1. WILLIS GL, Freelance CB
    A Historical Review on the Emerging Preclinical Interest Concerning the Role of Circadian Function in Parkinson's disease.
    Brain Res. 2017 Sep 25. pii: S0006-8993(17)30424.
    PubMed     Text format     Abstract available


    J Clin Pharmacol

  2. COLES LD, Tuite PJ, Oz G, Mishra UR, et al
    Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress.
    J Clin Pharmacol. 2017 Sep 22. doi: 10.1002/jcph.1008.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  3. YE BS, Jeon S, Yoon S, Kang SW, et al
    Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Sep 26. pii: jnnp-2017-316075.
    PubMed     Text format     Abstract available


    J Neurosci

  4. VAN WIJK BCM
    Is Broadband Gamma Activity Pathologically Synchronized to the Beta Rhythm in Parkinson's Disease?
    J Neurosci. 2017;37:9347-9349.
    PubMed     Text format    


    Lancet Neurol

  5. LATOURELLE JC, Beste MT, Hadzi TC, Miller RE, et al
    Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
    Lancet Neurol. 2017 Sep 25. pii: S1474-4422(17)30328.
    PubMed     Text format     Abstract available

  6. BLAUWENDRAAT C, Bandres-Ciga S, Singleton AB
    Predicting progression in patients with Parkinson's disease.
    Lancet Neurol. 2017 Sep 25. pii: S1474-4422(17)30331.
    PubMed     Text format    


    Mov Disord

  7. THEVATHASAN W, Debu B, Aziz T, Bloem BR, et al
    Pedunculopontine nucleus deep brain stimulation in Parkinson's disease: A clinical review.
    Mov Disord. 2017 Sep 28. doi: 10.1002/mds.27098.
    PubMed     Text format     Abstract available

  8. TESSITORE A, De Micco R, Giordano A, di Nardo F, et al
    Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease.
    Mov Disord. 2017 Sep 26. doi: 10.1002/mds.27139.
    PubMed     Text format     Abstract available

  9. ROSE SJ, Harrast P, Donsante C, Fan X, et al
    Parkinsonism without dopamine neuron degeneration in aged l-dopa-responsive dystonia knockin mice.
    Mov Disord. 2017 Sep 26. doi: 10.1002/mds.27169.
    PubMed     Text format     Abstract available

  10. BIUNDO R, Weis L, Abbruzzese G, Calandra-Buonaura G, et al
    Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.
    Mov Disord. 2017 Sep 27. doi: 10.1002/mds.27181.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  11. JANKOVIC J
    Parkinson disease: Exenatide - a drug for diabetes and Parkinson disease?
    Nat Rev Neurol. 2017 Sep 29. doi: 10.1038/nrneurol.2017.
    PubMed     Text format    


    Neurol Genet

  12. LYNCH DS, Loh SHY, Harley J, Noyce AJ, et al
    Nonsyndromic Parkinson disease in a family with autosomal dominant optic atrophy due to OPA1 mutations.
    Neurol Genet. 2017;3:e188.
    PubMed     Text format    


    Neurology

  13. POSTUMA RB, Anang J, Pelletier A, Joseph L, et al
    Caffeine as symptomatic treatment for Parkinson disease (Cafe-PD): A randomized trial.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004568.
    PubMed     Text format     Abstract available

  14. MOREAU C, Barton BR, Devos D
    Virtually reducing fall risk in Parkinson disease.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004581.
    PubMed     Text format    

  15. MAIDAN I, Rosenberg-Katz K, Jacob Y, Giladi N, et al
    Disparate effects of training on brain activation in Parkinson disease.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004576.
    PubMed     Text format     Abstract available


    Neurosci Lett

  16. GMITTEROVA K, Gawinecka J, Heinemann U, Valkovic P, et al
    DNA versus RNA oxidation in Parkinson's disease: which is more important?
    Neurosci Lett. 2017 Sep 26. pii: S0304-3940(17)30790.
    PubMed     Text format     Abstract available


    PLoS One

  17. YANG Y, Qin M, Bao P, Xu W, et al
    Secretory carrier membrane protein 5 is an autophagy inhibitor that promotes the secretion of alpha-synuclein via exosome.
    PLoS One. 2017;12:e0180892.
    PubMed     Text format     Abstract available

  18. BEN EL HAJ R, Salmi A, Regragui W, Moussa A, et al
    Evidence for prehistoric origins of the G2019S mutation in the North African Berber population.
    PLoS One. 2017;12:e0181335.
    PubMed     Text format     Abstract available

  19. HUANG SL, Hsieh CL, Wu RM, Lu WS, et al
    Test-retest reliability and minimal detectable change of the Beck Depression Inventory and the Taiwan Geriatric Depression Scale in patients with Parkinson's disease.
    PLoS One. 2017;12:e0184823.
    PubMed     Text format     Abstract available

  20. SHRESTHA S, Kamel F, Umbach DM, Beane Freeman LE, et al
    Nonmotor symptoms and Parkinson disease in United States farmers and spouses.
    PLoS One. 2017;12:e0185510.
    PubMed     Text format     Abstract available

  21. NACHEVA E, Mokretar K, Soenmez A, Pittman AM, et al
    DNA isolation protocol effects on nuclear DNA analysis by microarrays, droplet digital PCR, and whole genome sequencing, and on mitochondrial DNA copy number estimation.
    PLoS One. 2017;12:e0180467.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: